Disease/Infection News

RSS

Obama's U.N. speech could be 'turning point' in fight against human trafficking

"When President Obama made a landmark speech against modern slavery on Tuesday, many of us in the news media shrugged," but women survivors of human trafficking "noticed," Nicholas Kristof writes in his New York Times column.

28 Sep 2012

Large donors dictating direction of global health research, financing, essay says

"When it comes to getting aid right, an all-too-familiar problem seems to be balancing the priorities of rich governments with what communities actually want," AlertNet reports in an article examining an essay written by Oxford University researcher Devi Sridhar and published in PLOS Medicine.

28 Sep 2012

African leaders renew commitment to providing HIV treatment, prevention services

"African leaders meeting on the sidelines of the 67th session of the United Nations General Assembly called Wednesday for innovative solutions to accelerate the response to AIDS, tuberculosis and malaria and to advance health for people on the continent," the U.N. News Centre reports.

28 Sep 2012

Efavirenz drug may play a key role in brain damage

The way the body metabolizes a commonly prescribed anti-retroviral drug that is used long term by patients infected with HIV may contribute to cognitive impairment by damaging nerve cells, a new Johns Hopkins research suggests.

28 Sep 2012

Incarcerated patients with chronic HCV likely to achieve sustained viral response

Incarcerated patients with chronic hepatitis C virus (HCV) infection are just as likely to respond to treatment for the disease as patients in the community, according to findings published in the October issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases.

28 Sep 2012

Life Technologies receives FDA clearance for OpTmizer CTS T-cell expansion media

Life Technologies Corporation today announced it has received FDA 510(k) clearance for its OpTmizer CTS T-Cell Expansion Tissue Culture Medium – a reagent that is now cleared as a Class II medical device and offers cost- and time-saving advantages for transitioning studies from the research bench to clinical trials.

28 Sep 2012

Study finds major risk factors for HIV among U.S. Armed Forces personnel during DADT era

Same-sex partners and inconsistent condom use were among the major risk factors for HIV infection among U.S. Navy and Marines personnel during the "Don't Ask, Don't Tell" (DADT) era, reports a study in the October 1 issue of JAIDS: Journal of Acquired Immune Deficiency Syndromes.

27 Sep 2012

George Mason University research makes big breakthrough in HIV

New research showing how the HIV virus targets "veterans" or memory T-cells could change how drugs are used to stop the virus, according to new research by George Mason University.

27 Sep 2012

Key bacterial protein structures reveal one of the biochemical secrets behind multi-drug tolerance

The structures of key bacterial proteins have revealed one of the biochemical secrets that enables bacteria to outwit antibiotics.

27 Sep 2012

Women more likely to suffer infections related to urolithiasis

While more men than women develop kidney stones and other obstructions in the urinary tract, women are more than twice as likely to suffer infections related to the condition, according to a new study led by Henry Ford Hospital researchers.

27 Sep 2012

World working together to end polio

In a post on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, foundation Co-Chair Bill Gates writes about traveling to New York this week to deliver a speech to the U.N. on polio eradication, one of the top five global health priorities as described by U.N. Secretary-General Ban Ki-moon.

27 Sep 2012

British Society for Immunology, Springer partner to publish six books per year

Springer and the British Society for Immunology (BSI) have entered into an agreement to publish six books per year, to be included in Springer's long-running book series, Advances in Experimental Medicine and Biology.

27 Sep 2012

IRIN examines reaction to Global Fund's new funding approach

"The Global Fund to Fight AIDS, Tuberculosis and Malaria has released initial details on its new funding model, ... but as the fund works to finalize the model before next year, civil society is criticizing the process for being untransparent and rushed," IRIN reports in an article examining the draft model and reaction to it.

27 Sep 2012

Meeting needs of children living with, affected by HIV 'central' to PEPFAR mission

"Meeting the needs of children, including both children living with HIV and those affected by the disease in other ways, is not peripheral to PEPFAR's mission -- it is central," U.S. Global AIDS Coordinator Ambassador Eric Goosby writes in USAID's "DipNote" blog, adding, "It's a responsibility, and an opportunity as part of our push toward an AIDS-free generation."

27 Sep 2012

WHO urges health workers to be alert for patients exhibiting symptoms of new SARS-like virus

"The World Health Organization on Wednesday urged health workers around the world to report any patient with acute respiratory infection who may have traveled to Saudi Arabia or Qatar and been exposed to a new SARS-like virus confirmed in two people so far," Reuters reports.

27 Sep 2012

Coca Cola, Global Fund announce expansion of project to deliver medicines in rural areas

The Coca-Cola Company and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the expansion of a pilot project, called "Project Last Mile," that uses Coca Cola's "'expansive global distribution system and core business expertise' to help deliver critical medicines to remote parts of the world, beginning in rural Africa," Pharma Times reports.

27 Sep 2012

Easy steps to protect against spread of influenza

Flu season is here and Concentra is sharing some easy steps to protect against the spread of influenza, including seasonal flu vaccines available at all Concentra locations across the country. Concentra is a subsidiary of Humana Inc., one of the nation's leading health and well-being companies

27 Sep 2012

Presidential candidates should address HIV epidemic more directly

Following the XIX International AIDS Conference (AIDS 2012) in July, "delegates left Washington with a clear focus on achieving an AIDS-free generation," Chip Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, writes in the Huffington Post's "The Big Push" blog.

26 Sep 2012

Forbes features interview with president of Friends of Global Fight

Forbes features an interview with Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, in which she "discusse[s] her motivations for pursuing a career in international affairs and social change, her experience as a senior program officer at the [Bill & Melinda Gates Foundation], what lessons she learned during her time at Gates that are most applicable in her new executive role at Friends of the Global Fight, the current landscape of challenges and solutions, and the role of technology in accelerating progress."

26 Sep 2012

Sufficient resources needed to maintain progress against AIDS, TB, malaria

"This week, heads of state, celebrities and CEOs will attend U.N. Secretary General Ban Ki-moon's 'Every Woman, Every Child' dinner in New York," an event that "will highlight the amazing contribution of the Global Fund to Fight AIDS, Tuberculosis and Malaria to the health of women and children in developing countries," Lucy Chesire, executive director and secretary to the board of TB ACTION Group, writes in the Huffington Post's "The Big Push" blog.

26 Sep 2012

Disease/Infection News

Obama's U.N. speech could be 'turning point' in fight against human trafficking

Large donors dictating direction of global health research, financing, essay says

African leaders renew commitment to providing HIV treatment, prevention services

Efavirenz drug may play a key role in brain damage

Incarcerated patients with chronic HCV likely to achieve sustained viral response

Life Technologies receives FDA clearance for OpTmizer CTS T-cell expansion media

Study finds major risk factors for HIV among U.S. Armed Forces personnel during DADT era

George Mason University research makes big breakthrough in HIV

Key bacterial protein structures reveal one of the biochemical secrets behind multi-drug tolerance

Women more likely to suffer infections related to urolithiasis

World working together to end polio

British Society for Immunology, Springer partner to publish six books per year

IRIN examines reaction to Global Fund's new funding approach

Meeting needs of children living with, affected by HIV 'central' to PEPFAR mission

WHO urges health workers to be alert for patients exhibiting symptoms of new SARS-like virus

Coca Cola, Global Fund announce expansion of project to deliver medicines in rural areas

Easy steps to protect against spread of influenza

Presidential candidates should address HIV epidemic more directly

Forbes features interview with president of Friends of Global Fight

Sufficient resources needed to maintain progress against AIDS, TB, malaria

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News